BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
6.81
+1.06 (18.43%)
Mar 6, 2026, 4:00 PM EST - Market closed

BiomX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-37.38-17.73-26.17-28.32-36.23-30.09
Depreciation & Amortization
2.691.80.872.522.572.18
Stock-Based Compensation
2.561.851.061.533.242.89
Other Adjustments
-1.63-17.930.48-0.370.23-
Changes in Accounts Payable
-0.37-3.170.56-1.980.43-0.86
Changes in Accrued Expenses
-2.84-0.981.19-3.30.671.38
Changes in Unearned Revenue
--1.98--1.98-
Changes in Other Operating Activities
3.351.160.730.82-0.450.05
Operating Cash Flow
-28.29-36.98-21.29-29.09-27.57-24.45
Capital Expenditures
-0.01-0.03-0.05-0.11-3.68-1.01
Sale of Property, Plant & Equipment
0.120.0800.010-
Purchases of Investments
----13.5--49.78
Proceeds from Sale of Investments
--211.519.8539.93
Other Investing Activities
-0.66----
Investing Cash Flow
0.110.721.95-2.1116.17-10.86
Long-Term Debt Issued
----14.23-
Long-Term Debt Repaid
0.03-10.75-4.25---
Net Long-Term Debt Issued (Repaid)
0.03-10.75-4.25-14.23-
Issuance of Common Stock
18.0628.777.490.2923.060.21
Net Common Stock Issued (Repurchased)
18.0628.777.490.2923.060.21
Issuance of Preferred Stock
-21.27----
Net Preferred Stock Issued (Repurchased)
-21.27----
Other Financing Activities
-0.53-0.92-0.33---0.08
Financing Cash Flow
11.5438.372.90.2937.280.13
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.0700.010.11-0.03-
Net Cash Flow
-16.642.11-16.44-30.9125.88-35.17
Free Cash Flow
-28.3-37.01-21.34-29.2-31.26-25.46
Free Cash Flow Per Share
-19.64-48.84-78.97-185.86-228.33-209.72
Levered Free Cash Flow
-34.54-31.67-27.13-30.36-20.5-28.35
Unlevered Free Cash Flow
-37.61-47.75-22.07-29.33-34.03-28.52
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q